Abstract: A method for recognizing an electrical oscillation in an electrical power supply system, in which an electrical oscillation variable is determined for at least one measuring point in the power supply system. Parameters of an electrical oscillation are calculated on the basis of a time curve of the oscillation variable for the at least one measuring point, and the presence and type of an electrical oscillation is deduced using the parameters. To be able to provide correct parameters for assessing the oscillation in a timely fashion after the start of the oscillation, it is proposed that the number of those successive values of the oscillation variable from which the parameters of the electrical oscillation are calculated is adapted dynamically to the sequence of values of the oscillation variable.

Abstract: Compounds and compositions, their use and methods using the compounds and compositions for preventing an infection, e.g. an infection by a virus or bacterium, or treating an infection, e.g. a virus or bacterial infection, or treating a disease caused by an infection, e.g. a virus or bacterial infection, and a method of increasing the binding of virus neutralizing antibodies, an in vitro method of detecting virus-specific antibodies in a sample obtained from a subject, a compound for use in a method of detecting of virus-specific antibodies in a subject, and a kit for the detection of virus-specific antibodies.

Abstract: A composition for use in preventing an infection, or treating an infection, or treating a disease caused by an infection, the composition including a compound selected from the group of chitosan or a salt thereof, galactose, mannose, caffeine, and any combination thereof.

Abstract: The present invention relates to a method for acquiring tomographic images of a sample in a microscopy system, wherein the sample comprises a defined region, and wherein the method comprises determining a location in three-dimensional space of the defined region, wherein the method further comprises capturing an image of at least a part of the sample, and wherein the determination of the location in three-dimensional space of the defined region is based, at least in part, on the image of the part of the sample. The present invention also relates to a corresponding microscopy system and a computer program product to perform the method according to the present invention.

Abstract: The present invention relates to methods of providing biocompatible/biodegradable hydrogels obtained by crosslinking of biopolymers (for example polysaccharides or proteins) in the semi-solid (modelling-clay like) state at water content below 70% by weight. The resulting materials can be applied in medicine, pharmacy and/or in cosmetics.

Abstract: The invention relates to a method of imaging a sample, said sample mounted on a sample holder in an electron microscope, the electron microscope comprising an electron source for generating a beam of energetic electrons along an optical axis and optical elements for focusing and deflecting the beam so as to irradiate the sample with a beam of electrons. The sample holder is capable of positioning and tilting the sample with respect to the electron beam. The method comprises the step of acquiring a tilt series of images by irradiating the sample with the beam of electrons, and concurrently changing a position of the sample during acquisition of the images, so that each image is acquired at an associated unique tilt angle and an associated unique position.

Abstract: Embodiments described herein generally relate to methods of processing of biopolymers and applications utilizing these biopolymers.

Abstract: The present invention relates to methods of providing biocompatible/biodegradable hydrogels obtained by crosslinking of biopolymers (for example polysaccharides or proteins) in the semi-solid (modelling-clay like) state at water content below 70% by weight. The resulting materials can be applied in medicine, pharmacy and/or in cosmetics.

Abstract: The invention relates primarily to a processing method of biopolymers by means of solvent/solvent mixtures or multiphase solvent systems by means of which said polymers can be changed in their mechanical and qualitative features and processed more easily.

Abstract: Embodiments described herein generally relate to methods of homogeneous wetting of biopolymers, derivatives therefrom and synthetic polymers, and, their applications.

Abstract: The invention relates to a method of imaging a sample, said sample mounted on a sample holder in an electron microscope, the electron microscope comprising an electron source for generating a beam of energetic electrons along an optical axis and optical elements for focusing and deflecting the beam so as to irradiate the sample with a beam of electrons. The sample holder is capable of positioning and tilting the sample with respect to the electron beam. The method comprises the step of acquiring a tilt series of images by irradiating the sample with the beam of electrons, and concurrently changing a position of the sample during acquisition of the images, so that each image is acquired at an associated unique tilt angle and an associated unique position.

Abstract: Disclosed are macroscopic systems of highly concentrated, cross-linked biopolymers. The macroscopic system is created by combining a biopolymer with a cross-linking agent, submerging the resulting product in an aqueous solution which contains additional cross-linking agents, to allow the biopolymer to undergo a second cross-linking process. The resulting macroscopic biopolymer has an increased biopolymer concentration and increased longevity within the body.

Abstract: The present invention discloses a drug delivery system comprising at least one hydrophobic matrix and at least one pharmaceutically active compound. The hydrophobic matrix comprises at least one hydrophobic solid component and at least one hydrophobic liquid component. The pharmaceutically active compound may comprise a biological cell or a biopolymer. The hydrophobic matrix conserves the activity of and protects the functionality of the biological cell or biopolymer in hostile environment, at elevated temperature, cold temperatures or a combination thereof. The present invention also discloses the use of the drug delivery system in a kit for diagnostic or analytical purposes. Additionally, the present invention discloses the use of the drug delivery system to deliver the pharmaceutically active compound to a subject who has or is suspected of having a pathophysiological condition.

Abstract: The present invention discloses methods for manufacturing drug delivery composition comprising at least one pharmaceutically active compound, at least one anti-caking agent and at least one oil. The anti-caking agent and the oil form the matrix when mixed, which then embeds the pharmaceutically active compound.

Abstract: Disclosed are micronized hydrophilic systems of highly concentrated, cross-linked biopolymers. The system is created by combining a biopolymer with a cross-linking agent under mechanical kneading and allowing the biopolymer to undergo a cross-linking process followed by purification, drying and milling. The resulting micronized biopolymer system has an increased biopolymer concentration and increased longevity within the body.

Abstract: Disclosed are biocompatible composite nanoparticles and methods of preparing biocompatible composite nanoparticles. Also disclosed ate composite nanoparticles which are biocompatible, biodegradable and have numerous other advantages, and also examples of preparation of the nanoparticles and applications for intracellular delivery.

Abstract: Disclosed are methods of making stable nanoparticle suspensions wherein one or more nanoporous or mesoporous materials are used to absorb and remove one or more non-tolerated surfactants from the nanoparticle suspensions. Also provided are methods of making stable nanoparticle suspension formulations wherein one or more macromolecular or colloidal stabilizers or tolerated surfactants are simultaneously added to further stabilize the nanoparticle suspension formulation. Thus to prevent a collapse of the suspension, one exchanges or replaces the surfactants that are not tolerated, by one or more tolerated surfactants or by macro-molecular/colloidal stabilizers.

Abstract: A method for manufacturing a drug-delivery composition includes providing at least one pharmaceutically active compound, a dry powder comprising at least a polymer, and an aqueous solution. The dry powder, the pharmaceutically active compound and the aqueous solution are mixed to form a paste-like or semi-solid drug-delivery composition, wherein the aqueous solution is added in an amount of less than or equal to twice the total dry mass of the dry powder.

Abstract: A binder composition comprising a cold water soluble starch material and a plasticiser for use in the preparation of coating compositions.

Abstract: The present invention belongs to the field of sustained drug release, and provides drug delivery compositions and methods of manufacturing drug delivery compositions.